Join 22 others & invest in SAKEENAH

Early Adoption Discount

  • 1st.

    First Tranche

    Shares will be sold at a 12 % discount

    €0 share value remaining

    €74.86 Price/Share

  • 2nd.

    Second Tranche

    Shares will be sold at a 8 % discount

    €0 share value remaining

    €78.26 Price/Share

  • 3rd.

    Third Tranche

    Shares will be sold at a 5 % discount

    €0 share value remaining

    €80.81 Price/Share

  • 4th.

    Fourth Tranche

    Shares will be sold at a 0 % discount

    - share value remaining

    €85.07 Price/Share

Minimum investment size 500 500

How much do you want to invest?
in
Available for investment $171,274
Exchange rate applied for this proposal:
Number of shares to be purchased$
Price/Share before discount$
Note: This proposal accepts overfunding; remember it is optional whether the proposal owner decides to accept any overfunding commitments.
Invest Cancel

Why SAKEENAH?

Why invest?

Scalability: Our solution is scalable and has a huge market to address i.e., 475 Million specifically and 1.8 Billion in general. We are addressing global market not a country or region.

Strategic Backing: We are working with authorities likes of NHS and MoH to become a medically backed app by 2023.
... see more.

Notable Press

We were featured in Forbes Middle East during the early days of Covid-19 We were also covered by Khaleej Times, Dubai, United Arab Emirates

Join us to see more

Please login/register to see the Proposal Forcasts/Financials.

Join us to see more

Please login/register to see the Proposal Forcasts/Financials.

Latest Update

The Team

Chief Product Officer
Chief Content Officer
Chief Mental Health & Informatics Officer
Meet the Team


Offering mental well-being solutions to 475 million Muslims suffering from different issues related to mental health

Why SAKEENAH?

Scalability: Our solution is scalable and has a huge market to address i.e., 475 Million specifically and 1.8 Billion in general. We are addressing global market not a country or region.

Strategic Backing: We are working with authorities likes of NHS and MoH to become a medically backed app by 2023.

User Engagement: Our current user base is highly engaged where a user spends 5 minutes on average per session whereas users of an app like Calm, its shy of 2 minutes
Our Process to onboard Experts: We only work with qualified people to create content and there is extensive process in place to cross check and approve.

Our Team: We have qualified experts & professionals in different parts of our business such as Dr Hamada Altalib is the Chief Mental Health & Informatics Officer also chief editor and founder of Muslim Mental Health Journal USA & Associate Professor at Yale 

Our Traction: Currently having more than 15,000 users of the beta version with approx 600 paid users


Notable Press

We were featured in Forbes Middle East during the early days of Covid-19 We were also covered by Khaleej Times, Dubai, United Arab Emirates

The Business

Join us to see more

Please Login/register to see the proposal business.

25% of world population is affected by one or another type of common mental well-being problem for instance anxiety, stress, or depression. According to WHO, these people live 1 in 5 years as a year of disability. As per the same rate, there are approx. 475 million Muslims suffering with common mental well-being issues. In Muslim audience the problem is multi layered and deep rooted because 1) the problem is of huge scale, 2) there is lack of awareness 3) Accessibility of solutions. Just alone in the UAE & KSA, every 383 & 500 people out of 100,000 suffer with anxiety
This is where SAKEENAH comes in, it is a platform that is designed to address such issues by drawing from Islamic tradition, literature & mental health informatics technology. SAKEENAH aims to become a wholistic platform targeting Muslim’s addition to others that will be medically backed and accepted by various healthcare authorities & jurisdictions by offering different solutions for instance guided mindfulness & meditation, P2P Support groups & 1-2-1 sessions.
A platform that is aiming to acquire 3% of total SAM of 109m globally with more 400K paid users by the end of 2025 with net revenue of USD 52 million for the year 2025.

The number of Muslims globally, facing mental health issues, varies in different countries. From the lowest figure of 0.7 million in the Netherlands to a maximum of 45.4 million in Indonesia. The total number of Muslims using smartphones in the countries listed amounts to 204 million, with 34 million of probable facing mental health issues. The Company projects to capture one million users by the end of 2023, which is less than 3% of the total potential market. The Company has taken a conservative approach to estimating these figures and expects the actual figures to go much higher, resulting in higher than expected subscriptions and profits.

The proceeds will primarily be used in below ratio;
40% content development, platform development
40% on marketing
20% on operational cost

The following exit strategies have been considered and approved by the founders

1. We plan to offer a Share Buy back to all shareholders investing in this round five years following the issuance of shares. The price per share at which the Buy back will be offered shall be determined based on the market value of the Company at that point.

2. We aim to pay all shareholders an annual dividend whenever possible. This shall ultimately be at the discretion of the Board of Directors, who will approve the dividend payment based on the Company’s annual performance.

3. We anticipate a possible acquisition by a global competitor taking place over the next 5-7 years, which is very likely to yield a high multiple exits to any shareholders present at the time.

Public documents

The Investors

Be an early adopter

Early Adoption Discount

  • 1st.

    First Tranche

    Shares will be sold at a 12 % discount

    €0 share value remaining

  • 2nd.

    Second Tranche

    Shares will be sold at a 8 % discount

    €0 share value remaining

  • 3rd.

    Third Tranche

    Shares will be sold at a 5 % discount

    €0 share value remaining

  • 4th.

    Fourth Tranche

    Shares will be sold at a 0 % discount

    - share value remaining


Invest Now

Financials

Join us to see more

Please login/register to see the Proposal Forcasts/Financials.

Updates tab

Q&A

Join us to see more

Please login/register to see the Proposal questions and answers

Comments

Join us to see more

Please login/register to see the Proposal comments